MedTrace Logo

Real Word Study on Myopia Control With Repeated Red Light Therapy for Ages of 3~6 Years Old

NCT05811598 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-04-25

No results posted yet for this study

Summary

Repeated Red Light Therapy had been used as an amblyopia therapy for children as well as the myopia control in primary schools. However, ultra low lever of red light therapy with irradiance of 0.37mW and 0.60mW effectiveness and safety for 3\~ 6 year-old myopia treatment or slow myopia progression are seldom reported.

Conditions

  • Myopia
  • Amblyopia

Interventions

DEVICE

repeated ultra low lever red light

Myopia indoor lighting therapy

Sponsors & Collaborators

  • Beijing Airdoc Technology Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Chao He, PhD · Beijing Airdoc Technology Co., Ltd.

  • Daoman Xiang, MD, PhD · Guangzhou Women and Children's Medical Center

  • Wensi Shen, MD, PhD · Guangzhou Women and Children's Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-21
Primary Completion
2024-05-30
Completion
2024-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05811598 on ClinicalTrials.gov